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Abstract
Background: The relationships between total serum IgE levels and gene expression patterns in peripheral blood
CD4+ T cells (in all subjects and within each sex specifically) are not known.
Methods: Peripheral blood CD4+ T cells from 223 participants from the Childhood Asthma Management Program
(CAMP) with simultaneous measurement of IgE. Total RNA was isolated, and expression profiles were generated
with Illumina HumanRef8 v2 BeadChip arrays. Modeling of the relationship between genome-wide gene transcript
levels and IgE levels was performed in all subjects, and stratified by sex.
Results: Among all subjects, significant evidence for association between gene transcript abundance and IgE was
identified for a single gene, the interleukin 17 receptor B (IL17RB), explaining 12% of the variance (r
2) in IgE
measurement (p value = 7 × 10
-7,9×1 0
-3 after adjustment for multiple testing). Sex stratified analyses revealed
that the correlation between IL17RB and IgE was restricted to males only (r
2 = 0.19, p value = 8 × 10
-8; test for sex-
interaction p < 0.05). Significant correlation between gene transcript abundance and IgE level was not found in
females. Additionally we demonstrated substantial sex-specific differences in IgE when considering multi-gene
models, and in canonical pathway analyses of IgE level.
Conclusions: Our results indicate that IL17RB may be the only gene expressed in CD4+ T cells whose transcript
measurement is correlated with the variation in IgE level in asthmatics. These results provide further evidence sex
may play a role in the genomic regulation of IgE.
Background
Total serum immunoglobulin E (IgE) is a risk factor for
both the development of [1] and disease severity in
asthma [2]. The production of IgE is controlled by a
complex regulatory process that ultimately involves iso-
type class switching by mononuclear B lymphocytes, [3]
a CD4+ T cell dependent process [3]. However, to our
knowledge, there has been no analysis of the correlation
between genome-wide CD4+ T cell gene expression and
the variability in serum IgE among asthmatics.
Sex is a critical determinant of IgE level, with males
having a stronger tendency towards higher total IgE
than females [4]. Sex-related differences in IgE are pre-
sent early in life [5] and persist into adulthood [6].
Furthermore, there is growing evidence that the
underlying molecular underpinnings of IgE levels differ
between males and females. For example, we have pre-
viously demonstrated striking differences by sex in IgE
heritability estimates, with 83% of the variability in IgE
levels attributable to genetic factors in males, as com-
pared to 63% in females [7]. Moreover, evidence for
sexually-distinct genetic determinants of IgE has been
demonstrated in genome-wide linkage analyses of IgE in
some, [7] but not all studies [8].
Based on these findings we hypothesized that genome-
wide CD4+ T cell microarray analyses would provide
unique insights into genes that correlate with the varia-
bility in IgE level, and that sex would be an important
modifier of these correlations. To test these hypotheses
we explored the relationship between total serum IgE
levels and genome-wide gene expression transcript
abundance in a cohort of 223 young adults with asthma,
both in all subjects and within each sex specifically.
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Study population and sample collection
CAMP was a multicenter clinical trial of the effects of
anti-inflammatory medications in children with mild to
moderate asthma. All participants had asthma defined
by symptoms greater than twice per week, use of an
inhaled bronchodilator at least twice weekly or use of
daily medication for asthma, and increased airway
responsiveness [9]. Participant data relating to atopy was
obtained from the original CAMP dataset. The comple-
tion of the trial was followed by two four-year observa-
tion studies - CAMP Continuation Study (CAMPCS) 1
and 2. During Years 3 and 4 of CAMPCS/2, 299 chil-
dren at four of eight CAMP study centers (Baltimore,
Boston, Denver, St. Louis) participated in an ancillary
study of gene expression in asthma. The study visit
included questionnaire assessments of asthma severity,
measurements of pulmonary function, and collection of
peripheral blood for the simultaneous measurement of
cell count, total serum IgE, and CD4+ T cell gene
expression. Samples for RNA extraction were collected
with BD Vacutainer CPT tubes, (BD Diagnostics, Frank-
lin Lakes, New Jersey) placed on ice, centrifuged within
1 hour (20 minutes at 1700RCF) followed by mononuc-
lear cell layer isolation and suspension in 10 ml of PBS.
We isolated CD4+ T cells using anti-CD4+ microbeads
by column separation (Miltenyi Biotec, Auburn, CA),
[10] using 20 ul anti-CD4+ Micro beads per 10
6 total
cells. Pilot studies confirmed CD4+ cell yields of ~4 ×
10
6 at ≥ 95% purity per collection. Total RNA was
extracted using the RNeasyM i n iP r o t o c o l( Q I A G E N ,
Valencia, CA) [11] and stored at -80°C. 2100 Bioanayzer
(Agilent Technologies, Santa Clara, CA) analysis con-
firmed average total RNA yields of 2 ug per collection,
with minimal evidence of RNA degradation and 28S:16S
ratios approaching 2.0. Written informed consent was
obtained from participants. CAMP was approved by the
Institutional Review Boards of Brigham and Women’s
Hospital and the other participating centers.
Microarray hybridization and sample preprocessing
Expression profiles were generated with Illumina
HumanRef8 v2 BeadChip arrays (Illumina, San Diego
CA) using 100 ng of CD4+ total RNA from each sample
and the Illumina BeadStation 500G according to proto-
col [12]. Arrays were read using the BeadArray scanner
(Illumina) and analyzed using BeadStudio (version 3.1.7)
without background correction. Raw expression intensi-
ties were processed using the lumi package [13] with
background adjustment with RMA convolution [14] and
log2 transformation of each array. The combined set of
arrays was subsequently quantile normalized. The Gene
Expression Omnibus number for this dataset is
GSE22324.
Quantitative Real-Time PCR
For validation of our microarray results using real-time
PCR (RT-PCR) was performed on a subset of subjects
(n = 10) with the Taqman 7900 gene expression assay
using primers and probes from Applied Biosystems.
Quantitative RT-PCR analyses were performed in tripli-
cate with appropriate positive and negative controls.
The mRNA values were normalized with TATA binding
protein (TBP) serving as the internal control. Relative
mRNA expression levels were calculated using the delta
cycle time (Ct) method.
Serum Total IgE
Total serum IgE was measured by radioimmunosorbent
assays from blood samples collected during the
CAMPCS/2 visits. Serum IgE was transformed to the
log10 scale for analysis.
Pulmonary Function and Methacholine challenge testing
Pre- and post-bronchodilator spirometry was performed
according to American Thoracic Society recommenda-
tions with a volume-displaced spirometer, and airway
responsiveness was assessed by methacholine challenge
with the Wright nebulizer tidal breathing technique [15].
Statistical analysis
All expression microarray analyses were performed in R
2.9/Bioconductor [16,17]. Variance-based non-specific fil-
tering was used to remove uninformative probes specifying
a minimum interquartile range of 1 on the log2 scale. We
used the Limma package [18] to analyze the linear correla-
tion between gene expression level and log10IgE measure-
ments both unadjusted for covariates and adjusted for age,
sex (where appropriate), ethnicity, and center of sample
collection. Joint and sex-stratified analyses were performed
to assess the influence of sex. To control for multiple test-
ing, we used the FDR procedure as proposed by Benjamini
and Hochberg [19] with a threshold of 0.05 to define sta-
tistical significance. To generate multivariate linear models
accounting for the large-p (expression transcript levels)
small-n (number of subjects) problem, and to accommo-
date correlations among predictor variables, we used the
least absolute shrinkage and selection operator (LASSO)
[20] estimation. LASSO is a coefficient shrinkage and vari-
able selection method that achieves model sparsity by set-
ting coefficients of many irrelevant transcripts to 0. The
LASSO analysis was performed using the least angle
regression (LARS) algorithm, utilizing 5-fold cross-valida-
tion, as implemented in the R package lars. [21] We per-
formed Canonical Pathway Analyses using Ingenuity
Pathway Analysis ([IPA], Ingenuity Systems
®, http://www.
ingenuity.com) software (utilizing gene transcripts attain-
ing nominal levels of significance [p < 0.05] in all subjects
and within males and females specifically).
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Expression data from peripheral blood CD4+ T cells was
measured in 299 asthmatics from CAMP; 223 of these
(75%) also had a simultaneous measurement of total
serum IgE. The baseline characteristics of the 223
CAMP subjects included in this analysis are presented
in Table 1. There were no significant differences in any
clinical variable between subjects with and without IgE
measurement. We tested for evidence of linear associa-
tion between gene transcript abundance in peripheral
blood CD4+ T cells and total serum IgE. After non-spe-
cific gene filtering, 13,310 (64.5%) transcripts demon-
strating variable expression across samples were
considered for testing.
All Subjects
Single Gene Regressive Strategies
Significant evidence for association between transcript
abundance and total serum IgE was identified for a sin-
gle gene, interleukin 17 receptor B (IL17RB), explaining
12% of the variance (r
2) in total serum IgE measurement
(p value = 7 × 10
-7,9×1 0
-3 after adjustment for multi-
ple testing, see Figure 1A). Similar results were noted in
analyses restricted to the 168 white subjects (IL17RB, p
value = 2 × 10
-6,2×1 0
-2 after adjustment for multiple
testing), and technical validation by RT-PCR confirmed
the association between total serum IgE levels and
I L 1 7 R Bt r a n s c r i p ta b u n d a n c e( ap o s i t i v ec o r r e l a t i o n
between delta CT and total serum IgE [r
2 0.37, p value
0.03]). We re-analyzed our data with the inclusion of a
quadratic term for gene expression level but found no
significant findings of association under this non-linear
modeling assumption. A list of the top 50 transcripts is
presented in Additional File 1. No differences were
noted in models additionally adjusting for measures of
severity including methacholine PC20 (a measurement of
airway responsiveness) or pre-bronchodilator FEV1 (a
measurement of pulmonary function). Of note, explora-
tory analyses of the relationship between IL17RB tran-
script abundance and other intermediate asthma
phenotypes revealed evidence of association with both
Table 1 Baseline characteristics of subjects from the Childhood Asthma Management Program (CAMP)
Variable Median (interquartile range) or Count (%)
All (n = 223) Males (n = 134) Females (n = 89)
Age, years 20 (19-22) 20 (19-22) 21 (19-23)
Sex, female 89 (40%) - -
Ethnicity, white 168 (75%) 97 (72%) 71 (80%)
African-American 42 (18%) 26 (19%) 16 (18%)
Hispanic 13 (6%) 11 (8%) 2 (2%)
Total serum IgE (IU/ml) 356 (145-924) 480 (150-1172) 253 (133-597)
Atopy *† 200 (90%) 122 (91%) 78 (88%)
Allergen Specific Skin Tests *‡
Dust Mites
Dermatophagoides farinae 97 (44%) 61 (46%) 36 (40%)
Dermatophagoides pternohyssinus 92 (41%) 58 (43%) 34 (38%)
Cockroaches
Blattella germanica 66 (30%) 41 (31%) 25 (28%)
Periplaneta Americana 56 (25%) 36 (27%) 20 (22%)
Atopic dermatitis *‡§ 48 (22%) 72 (43%) 15 (31%)
Allergic rhinitis *‡§ 92 (42%) 56 (43%) 33 (35%)
FEV1 (liters) ‡ 3.65 (3.13-4.19) 4.04 (3.65-4.48) 3.13 (2.86-4.48)
FEV1/FVC (%) ‡ 78 (72-83) 76 (71-82) 79 (75-84)
PC20 (mg/ml) ‡ 2.49 (1.64-4.88) 3.01 (1.88-4.88) 1.95 (1.37-4.53)
Used Inhaled Corticosteroids ‡║ 50 (25%) 24 (21%) 26 (31%)
Used Oral Prednisone ‡║ 12 (6%) 1 (1%) 11 (13%)
* Data on these atopy variables was recorded at enrollment into the CAMP trial (~10-12 years prior to both the gene expression and total serum IgE
measurement).
† Atopy defined as subjects with at least one positive allergen skin test.
‡ Data missing for skin test positive responses to Blattella Germanica in 1 subject, atopic dermatitis FEV1 and FEV1/FVC ratio in 9 subjects, for inhaled
corticosteroids or oral prednisone in 23 subjects, and PC20 in 34 subjects.
§ Atopic dermatitis and allergic rhinitis were defined by physician diagnosis.
║ Refers to subjects who used these medications within 7 days of both the gene expression and total serum IgE measurement.
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-6)a n d
methacholine PC20 (p value = 4 × 10
-4).
Due to the well-documented sexual dimorphism of
IgE levels, we assessed whether sex would modify the
association between gene expression and total serum
IgE by repeating the analysis for males (n = 134, 60%)
and females (n = 89, 40%) separately. These analyses
revealed that the correlation between IL17RB and total
serum IgE was restricted to males only (r
2 = 0.19, p
value = 8 × 10
-8,1×1 0
-3 after adjustment for multiple
testing), and was not observed in females (r
2 =. 0 3 ,p
value = 0.13, 1 after adjustment for multiple testing).
Formal testing confirmed the observed differences in
correlation of IL17RB and IgE in males and females was
statistically significant (test for sex-specific interaction p
<0 . 0 5 ,s e eF i g u r e1 B ) .I ti si m p o r t a n tt on o t et h a tt h e
differences in correlation between IL17RB and IgE were
not due to baseline differences in IL17RB levels between
males and females (mean log2 IL17RB level 7.5 in both
males and females, t-test p value 0.5 for the difference).
No other transcript was associated with total serum IgE
among either males or females after correction for mul-
tiple testing. Plots of the linear correlation between
IL17RB level and total serum IgE in males and females
specifically, are presented in Figure 1B. The gene tran-
script with the strongest correlation with total serum
IgE among CAMP females (gamma-aminobutyric B
receptor 1 [GABBR1], unadjusted p-value 9 × 10
-4)d i d
not remain significant after adjustment for multiple test-
ing (p = 0.9998). Lists of the top 50 transcripts for both
males and females are presented in Additional Files 2, 3.
Next we examined the degree of overlap in the corre-
lations between gene transcript measurement and total
serum IgE between males and females. At an arbitrary
cutoff (p value < 0.05), there were 872 and 154 tran-
scripts demonstrating correlation with total serum IgE
among males and females, respectively. Only 16 of these
1010 unique transcripts (1.6%) were significantly corre-
lated with total serum IgE in both males and females;
and this result falls within the 95% confidence interval
([95% CI] 5-17) of the number of transcripts that should
overlap by chance alone. At a more liberal threshold for
inclusion of the results from females (p < 0.1), only 38
of 1205 unique transcripts (3.1%) overlap. At a more
conservative threshold (p < 0.01) there were no tran-
scripts common to both males and females.
We considered whether our findings of association in
males but not females could be attributable to differ-
ences in sample size. Though power was somewhat
lower in females due to the smaller number of subjects
(89 females vs. 139 males), power was very high (>91%)
to detect correlations half as strong as those observed
among males (power 91.4% to detect an r
2 of 0.09 in
the 89 CAMP females).
LASSO
Next we evaluated whether an alternate multi-gene
modeling approach utilizing 5-fold cross validation (the
LASSO method) could both confirm our findings of
association from single gene regressive strategies, and
could identify additional determinants of total serum
IgE levels. Among all subjects, the optimal multivariate
model included 17 transcripts (including IL17RB), of
which 16 map to unique HUGO gene identifiers (see
Additional File 4). Consistent with our single gene
regressive strategy the best fitting model includes
Figure 1 The Correlation Between CD4+ Lymphocyte Measurement of IL17RB and Serum IgE. Figure 1A and 1B represent plots of log2-
transformed gene expression measurement of IL17RB (on the x-axis) vs. log10-transformed total serum IgE measurement (on the y-axis), with
regression lines, for all subjects without (1A) and with (1B) consideration of male (in blue) and female (pink) sex. Figure 1C represents a plot of
the (-) delta cycle time from the real time-polymerase chain reaction of measurement of IL17RB (on the x-axis) vs. log10-transformed total serum
IgE measurement (on the y-axis) in all subjects.
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sion coefficient. Among males, the optimal multivariate
model included 30 transcripts, including 6 that overlap
with the best fitting regression model for all subjects:
ASB9, H2A histone family, member J (H2AFJ), hexose-
6-phosphate dehydrogenase (H6PD), IL17RB, poly(A)
binding protein interacting protein 1 (PAIP1), and
PVALB (see Additional File 5). Again, IL17RB was the
transcript with the largest estimated regression coeffi-
cient among males. For females, LASSO selected the
null model as its best prediction model, which suggests
that none of the genes were informative in predicting
IgE level.
Ingenuity Canonical Pathway Analysis
To better understand the combinatorial effect of multi-
ple gene transcripts on IgE regulation we performed
canonical pathway analyses. Of the 763 transcripts
demonstrating nominally significant (p < 0.05) correla-
tion with total serum IgE, 652 (85%) map to a unique
HUGO gene id and were used for IPA canonical path-
way analysis. Among all subjects, enrichment for six
pathways was observed (Fisher’s exact p < 0.05) includ-
ing the antigen presentation pathway, propanoate meta-
bolism, interferon signaling, primary immunodeficiency
signaling, the coagulation system, and the pantothenate
and CoA biosynthesis pathway (see Figure 2A). Similar
to the regression models, sex-stratified pathway analysis
revealed different patterns of pathway enrichment
between males and females. Among males, nominal evi-
dence for enrichment was observed for 13 pathways
(Figure 2B). Among females, enrichment was observed
for 6 pathways (Figure 2C), including strong evidence of
enrichment for the interferon signaling pathway in
females (p = 3.0 × 10
-6). Notably, there were no signifi-
cant canonical pathways in common between males and
females. Additional information about the canonical
pathway analyses, including lists of differentially
expressed genes within the pathways are included in
Additional Files 6, 7, 8. Of note, IL17RB is not currently
a constituent of an Ingenuity canonical pathway.
Discussion
This is the first study to correlate genome-wide CD4+ T
cell transcript abundance with IgE level in humans and
is, to our knowledge, the largest gene-expression study
of as asthma-related quantitative phenotype published to
date. Our results indicate that IL17RB may be the only
gene expressed in CD4+ T cells whose transcript mea-
surement is correlated with the variation in IgE level in
asthmatics. Given that IgE level is strongly influenced by
environmental factors (such as allergen exposures) it is
surprising that 12% of the variation in IgE can be
explained by IL17RB transcript measurement, a correla-
tion that is substantially greater than that explained
genetic determinants from three significant genomic
regions (r
2 = 1.9%) identified in a recent genome-wide
association study of IgE [22].
While it is often not possible within the confines of a
cross-sectional epidemiologic study to determine the
cause and effect relationship between two correlated
variables, abundant molecular biologic evidence suggests
that elevation of IL17RB should occur upstream from
increases in IgE. IL17RB, located on chromosome
3p21.1, is the receptor for interleukin 17 B (IL17B) but
has much higher binding avidity to interleukin 17 E
([IL17E] also known as IL25, IL-17Rh1, and Evi27 in the
mouse) [23]. While structural homology places the
IL17E-IL17RB ligand-receptor pathway within the IL17
family, as opposed to IL17A and IL17F which are cyto-
kines characteristic of Th17 cells, [24] several groups
have demonstrated that the IL17E-IL17RB pathway is a
strong inducer of Th2 responses [25]. In humans,
IL17RB expression has been demonstrated on the sur-
face of lung fibroblasts, [26] prominently on activated
CD4+ Th2 memory cells, [27] and recently in basophils
[28]. Comparable to our findings, IL17RB has recently
been shown to be the most differentially expressed gene
in allergen challenged peripheral blood mononuclear
cells from patients seasonal allergic rhinitis compared to
healthy controls [28]. Thymic stromal lymphopoietin
activated DCs appear to provide an important activating
signal allowing IL17RB+ Th2 memory cells to respond
to IL17E [27]. Elevated IL17E expression results in ele-
vated Th2 cytokine production, [29] asthma severity,
and elevations in IgE [30].
Another finding of our analyses is that the magnitude
of the relationship between patterns of CD4+ lympho-
cyte gene expression and total serum IgE levels is sub-
stantially different between males and females. Several
lines of evidence are provided, including: strong associa-
tion of IL17RB transcript abundance with IgE levels in
males (r
2 = 19%), but not in females (r
2 =3 % ) ;e v i d e n c e
for a multivariate gene signature of total IgE levels in
males, but not in females; and discrete, non-overlapping
canonical gene pathway enrichment in each sex. Nota-
bly, we found limited statistical evidence to suggest that
there is significant overlap between CD4+ T cell genes
whose transcript measurements correlate with IgE level
in both male and female asthmatics. Our work stands
with a body of literature now implicating an important
role for sex in the heritability, genome-wide linkage ana-
lyses, [7] and genome-wide gene expression analyses (
this
report) of IgE, and strongly support the notion that
genetic and genomic studies of IgE should consider the
role of sexual dimorphism.
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among the largest gene expression studies of asthma and
allergy to date it is important to note that sample size
may still be an important limitation of our analyses. The
imbalance in sample size between males and females in
this study, and the inherently lower mean values of IgE
levels in females can further reduce statistical power.
Though our power calculations suggest ample power
(>90%) to detect the male-specific associations in our
female sample, replication in larger sample sizes could
help to determine if the lack of overlap we note between
males and females is primarily an issue of the magnitude
Figure 2 Canonical Pathway Analysis of Serum IgE in CD4+ Lymphocytes. Figures A-C represent the results of Canonical Pathway Analyses
using Ingenuity Pathway Analysis ([IPA], Ingenuity Systems
®, http://www.ingenuity.com) software in all subjects, males, and females respectively.
The significance of the association between the our data set and identified pathways from the Ingenuity Pathway Analysis library of canonical
pathways was measured as a ratio of the number of genes from our dataset that map to the pathway divided by the total number of molecules
that exist within the canonical pathway (presented as a line plot). Fischer’s exact tests were used to calculate p-values (presented as -log10 p
values in a bar graph). In all subjects 763 transcripts demonstrated nominally significant (p < 0.05) correlation with total serum IgE. Of these 763
transcripts, 652 (85%) mapped to a unique HUGO gene id and were used for IPA canonical pathway analysis. Six pathways were nominally
significant using a Fisher’s exact test and are listed in Figure 2A. Among males, 900 transcripts were correlated with total serum IgE, 873 (97%)
mapped to a unique HUGO gene id, and thirteen pathways were significant (Figure 2B). Among females, 158 transcripts were correlated with
total serum IgE, 154 (97%) mapped to unique HUGO gene ids, and six pathways were significant (Figure 2C).
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regulation of IgE. In addition, our gene expression ana-
lyses include gene transcript measurements from unsti-
mulated peripheral blood CD4+ lymphocytes in a
population of adolescents and young adults recruited on
the basis of childhood asthma. We urge caution in extra-
polating our findings to other populations and cell types.
Finally, while an assessment of IL17RB protein levels
would provide additional supportive information, we do
not have intact CD4+ lymphocytes enabling suitable cell
surface protein quantification.
While the precise role that sex plays in the genomic
regulation of IgE is unknown, sex differences in the
immune environments experienced by CD4+ T cells are
well described. In animals, females are more likely to
develop a Th1 response after antigen challenge, except
during pregnancy when a Th2 environment dominates
[31]. Although little is known about the role sex could
play in IL17RB pathway regulation, some evidence sug-
gests that IL17RB level may influence the response to
sex hormones [32]. We recently demonstrated sex-speci-
fic effects of TSLP polymorphisms on the regulation of
specific, and total serum IgE in children with asthma
[33]. This is intriguing given that TSLP activated dendri-
tic cells (TSLP DCs) appear to be one of the most
potent stimuli of IL17RB expression [27].
Though we have limited evidence that single genes,
or genetic models strongly correlate with IgE level
among females, it is intriguing that the canonical path-
way most significantly correlated with IgE in females
was the interferon signaling pathway (p = 3 × 10
-6),
particularly in light of prior studies suggesting the
importance of interferon-g (INFG) in the female (more
than male) allergic response [34]. In mice, females
demonstrate increased T-cell proliferative responses,
[34] and consistently produce increased INFg [35] in
response to antigen challenge compared with their
male counterparts. In humans, females have been
shown to increase INFg levels in response to a variety
of stimuli [36]. Thus, our observation of differential
down-regulation of the IFN signaling in females (but
not in males) with higher levels of IgE is consistent
with these prior studies and suggests an important reg-
ulatory role for interferon signaling in the female aller-
gic response.
Conclusions
Our results indicate that IL17RB may be the only gene
expressed in CD4+ T cells whose transcript measurement
is correlated with the variation in IgE level in asthmatics.
We have demonstrated that sex is a critical modifier of the
correlation between the CD4+ T cell transcriptome and
IgE, and suggest that such sex-specific modification should
be consideration in future studies of IgE.
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